Atrium Therapeutics Inc (RNA)
$8.27 +0.12% Close Oct 30, 2026 Live
Atrium Therapeutics stock today
Atrium Therapeutics closed at $8.27 on October 30, 2026, up 0.12% on the day. Its market value is $141 million.
$10.00$15.00
MarMayJulSep
| Period | RNA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -0.1% | -0.9% |
| 3 months | -27.8% | +2.1% |
Key statistics
- Market value
- $141M
- 52-week range
- $7.61 to $16.54
- Next report
- Nov 9, 2026 (estimated)
About Atrium Therapeutics
Biopharmaceutical company developing therapies for rare genetic and neurological diseases.
Sector: Health Care
More on Atrium Therapeutics
- Financials: revenue, earnings and segmentsRevenue +71% in the year to Dec 2025
No forecast, no recommendation. This page describes Atrium Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.